melanotan-ii has been researched along with tyrosine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, AKY; Fu, WY; Ip, NY; Lau, JKY; Lau, SF; Shen, Y; Tian, M | 1 |
1 other study(ies) available for melanotan-ii and tyrosine
| Article | Year |
|---|---|
Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer's disease transgenic mouse model.
Topics: alpha-MSH; Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Hippocampus; Humans; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Peptides, Cyclic; Receptors, Melanocortin; Tyrosine | 2021 |